Form 8-K - Current report:
SEC Accession No. 0000950123-09-029538
Filing Date
2009-08-04
Accepted
2009-08-04 15:38:05
Documents
6
Period of Report
2009-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. b76630e8vk.htm 8-K 14747
2 EX-1.1 UNDERWRITING AGREEMENT DATED AUGUST 4, 2009 b76630exv1w1.htm EX-1.1 159527
3 EX-5.1 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. b76630exv5w1.htm EX-5.1 8189
4 EX-99.1 PRESS RELEASE OF ARIAD PHARMACEUTICALS, INC., DATED AUGUST 4, 2009 b76630exv99w1.htm EX-99.1 4930
5 GRAPHIC b76630b7663001.gif GRAPHIC 2903
6 GRAPHIC b76630b7663002.gif GRAPHIC 6344
  Complete submission text file 0000950123-09-029538.txt   201976
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

EIN.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21696 | Film No.: 09983461
SIC: 2836 Biological Products, (No Diagnostic Substances)